苏交科(300284) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥879,169,765.54, representing a 0.75% increase compared to ¥872,602,693.92 in the same period last year[5] - Net profit attributable to shareholders for Q1 2023 was ¥50,398,382.17, reflecting a 14.34% increase from ¥44,077,470.45 year-on-year[5] - The total revenue for Q1 2023 was approximately CNY 1,090.78 million, a decrease of 7.83% compared to CNY 1,183.79 million in Q1 2022[26] - The net profit for Q1 2023 was CNY 42.93 million, an increase of 10.77% from CNY 38.83 million in Q1 2022[24] - Operating profit for Q1 2023 was CNY 51,231,517.90, slightly down from CNY 52,287,563.08 in the previous period[23] - The total comprehensive income for Q1 2023 was CNY 46.26 million, an increase of 40.06% from CNY 33.02 million in Q1 2022[24] - The basic and diluted earnings per share for Q1 2023 were both CNY 0.0399, compared to CNY 0.0349 in Q1 2022, reflecting a growth of 14.34%[24] Cash Flow and Investments - The net cash flow from operating activities improved by 18.24%, amounting to -¥333,679,144.00 compared to -¥408,101,208.89 in the previous year[5] - The cash flow from operating activities showed a net outflow of CNY 333.68 million, improving from a net outflow of CNY 408.10 million in the same period last year[26] - The company experienced a net cash outflow from investing activities of CNY 156.22 million, compared to a significantly higher outflow of CNY 1,019.68 million in the previous year[26] - The net cash inflow from financing activities was CNY 276.08 million, an increase from CNY 144.30 million in Q1 2022[27] - The cash flow from financing activities increased by 91.32% to ¥27,607.98 million, compared to ¥14,430.23 million in the same period last year[11] Assets and Liabilities - The total assets at the end of Q1 2023 were ¥15,121,210,083.24, a decrease of 2.50% from ¥15,509,265,228.61 at the end of the previous year[5] - Total current assets decreased to CNY 11,910,315,954.00 from CNY 12,251,596,903.47, a decline of 2.77%[20] - Total liabilities decreased to CNY 6,489,687,201.97 from CNY 6,920,931,087.99, a reduction of 6.22%[21] - Total non-current assets decreased to CNY 3,210,894,129.24 from CNY 3,257,668,325.14, a decrease of 1.44%[20] - Cash and cash equivalents at the end of the period were CNY 2,281,350,893.83, down from CNY 2,498,607,484.87, a decrease of 8.71%[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 33,871[12] - The company reported a total of 291,421,794 restricted shares as of March 31, 2023, with no shares released during the period[16] - The company has a total of 373,969,384 restricted shares remaining after 18,024,000 shares were released during the period[16] - The largest shareholder, Zhujiang Group, holds 163,361,376 shares, representing a significant portion of the company's equity[14] - The company has a total of 24,000,000 shares held by the Tongyi Xingchun No. 1 Private Securities Investment Fund[15] - The company has a total of 48,570,299 shares held by the Guangzhou Small and Medium Enterprises Development Fund[14] - The company’s major shareholders include several private investment funds, indicating a diverse ownership structure[14] - The company has not disclosed any related party transactions among the top ten shareholders[14] Research and Development - Research and development expenses increased by 41.55% to ¥4,640.45 million, up from ¥3,278.25 million in the same period last year[11] - Research and development expenses increased to CNY 46,404,490.19, compared to CNY 32,782,479.15, marking a significant rise of 41.67%[23] Management Changes - The company appointed Wang Renzhao as the new financial officer effective from the board meeting date[18] - The company experienced a change in non-independent directors with Han Wei being appointed as a new non-independent director[17]